Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Daiken Medical CoTSE:7775 +0.24%62 ROA % is 7.40% as of Mar. 2026, which is 8% below its 10-year median of 8.01. GuruFocus rates TSE:7775 with a GF Score™ of 62/100 and a GF Value™ of 円541.84 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 854 Medical Devices & Instruments companies, Daiken Medical Co ranks better than 81.97% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Daiken Medical Co's annualizedNet Income for the quarter that ended in Mar. 2026 was 円822 Mil.
Daiken Medical Co's average Total Assets over the quarter that ended in Mar. 2026 was 円11,097 Mil. Therefore, Daiken Medical Co's annualized ROA % for the quarter that ended in Mar. 2026 was 7.40%.
The historical rank and industry rank for Daiken Medical Co's ROA % or its related term are showing as below:
TSE:7775'
s ROA % Range Over the Past 10 Years
Min: 6.21 Med: 8.01 Max: 11.79
Current: 8.29
During the past 13 years, Daiken Medical Co's highest ROA % was 11.79%. The lowest was 6.21%. And the median was 8.01%.
TSE:7775's ROA % is ranked better than 81.97% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 0.575
vs TSE:7775: 8.29
Daiken Medical Co (TSE:7775) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is two times the semi-annual (Mar. 2026) net income data. The Revenue data used here is two times the semi-annual (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Daiken Medical Co ROA % Related Terms
Daiken Medical Co ROA % Historical Data
* Premium members only.
The historical data trend for Daiken Medical Co's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Daiken Medical Co's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Daiken Medical Co ROA % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Daiken Medical Co's ROA % distribution charts can be found below:
* The bar in red indicates where Daiken Medical Co's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Daiken Medical Co (TSE:7775) has a ROA % of 7.40% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Daiken Medical Co and its competitors. This is near median its historical median of 8.01. Over the past decade, Daiken Medical Co's ROA % has ranged from 6.21 to 11.79. According to the industry distribution chart, Daiken Medical Co ranks #154 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 18%.
Is Daiken Medical Co's ROA % too high?
Daiken Medical Co's current ROA % of 7.40% is near median its 10-year median of 8.01. Over the past 10 years, this metric has ranged from a low of 6.21 to a high of 11.79. The Medical Devices & Instruments industry median ROA % is 0.58. Daiken Medical Co's value of 7.40% is 1187% above this industry median. Based on the distribution chart, Daiken Medical Co ranks #154 out of 854 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Daiken Medical Co has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Daiken Medical Co's ROA % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Daiken Medical Co ranks #154 out of 854 companies for ROA %. This places Daiken Medical Co in the top 18% of its industry — outperforming the majority of peers. The industry median ROA % is 0.58. Daiken Medical Co's value of 7.40% is 1187% above this benchmark. Historically, Daiken Medical Co's own ROA % has ranged from 6.21 to 11.79 over the past decade. While the company's 10-year median is 8.01 vs. the industry median of 0.58, Daiken Medical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Devices & Instruments company?
The median ROA % among Medical Devices & Instruments companies is 0.58, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Daiken Medical Co's current ROA % of 7.40% is 1187% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Daiken Medical Co and its competitors. For the Medical Devices & Instruments industry, the median ROA % is 0.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Daiken Medical Co's current ROA % is 7.40%, which is near median its own 10-year median of 8.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daiken Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Daiken Medical Co (TSE:7775) is currently considered Modestly Undervalued. The stock's GF Value™ is 円541.84, compared to a current price of 円426.00 — trading 21.4% below its estimated fair value. The current ROA % is 7.40%, which is near median its 10-year median of 8.01 and 1187% above the Medical Devices & Instruments industry median of 0.58. Daiken Medical Co's overall GF Score™ is 62/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Daiken Medical Co (TSE:7775), the current ROA % is 7.40% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Daiken Medical Co (TSE:7775) Overvalued in 2026?
Based on GuruFocus' analysis, Daiken Medical Co stock appears to be undervalued.
The current stock price of 円426.00 is trading 21.4% below its estimated GF Value™ of 円541.84.
GuruFocus considers Daiken Medical Co to be Modestly Undervalued.
Key valuation signals for TSE:7775:
ROA %: 7.40% (near median its 10-year median of 8.01)
GF Value™: 円541.84 vs. price of 円426.00 (21.4% below fair value)
Industry Position: 1187% above the Medical Devices & Instruments median (#154 of 854)
No single metric tells the full story. See the TSE:7775 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Daiken Medical Co Ltd manufactures and sells medical equipment. The product line includes - Coopdech syrinjector, Coopdech Syrinjector PCA device, Coopdech Balloonjector, Coopdech Endobronchial blocker tube, Coopdech double-lumen endobronchial tube, Fit fix suction container system, Wet disinfectant mat, and others.
62GF Score
Get the complete analysis for TSE:7775
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7775 has been successfully added to your 
